Shangrong Medical: Stock trading has experienced abnormal fluctuations, and the arbitration matter of the company's wholly-owned subsidiary has been resolved.

Shang Rong Medical announced that the trading price of the company's stock has deviated by more than 20% from the closing price for two consecutive trading days, indicating abnormal fluctuations in stock trading. The company's wholly-owned subsidiary, Anhui Shang Rong, was subjected to arbitration for not completing the development and construction of real estate land as stipulated in the contract. The applicant has recently withdrawn the arbitration request, and the impact of this matter on the company has been eliminated, and will not have a significant impact on the company's current or future profits. There are no major undisclosed matters involving the company, its controlling shareholder, or its actual controller, and there have been no transactions of the company's stock by the controlling shareholder or actual controller during the abnormal stock movement period.